#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Emma Boyle Email
Financial Consultant . Neumentum
Morristown, NJ
Locatione********@neumentum.com
Primary EmailHow to contact Emma Boyle
Join and see Emma's contact info for free!e********@neumentum.com
GROWJO
The Free Company & People Database
Current Roles
Neumentum
Get all of our best features!
About
Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceutical company with product candidates that have the potential to provide the benefits of safe and effective pain management without the risks of abuse, misuse and diversion seen with opioids, or opioid-induced side effects including potentially life-threatening respiratory depression. Neumentum has two lead product candidates being developed to directly help address the opioid crisis. NTM-006, a Phase 2 novel oral analgesic with a target indication for moderate to moderately severe chronic pain, was licensed in late 2019 from Janssen Pharmaceuticals NV and McNeil Consumer Pharmaceuticals Co., both part of the Johnson & Johnson Family of Companies. NTM-001 is a Phase 3-ready IV formulation of Toradol (ketorolac), with recent Phase I results showing that it may provide consistent, steady blood plasma levels of ketorolac over 24 hours and durable analgesic effect. This Phase I study is part of a program supporting what has the potential to be the first-ever NSAID approved for continuous infusion. Neumentum is led by a world-wide executive team of biotech and pharmaceutical industry leaders who have extensive experience in pain and neurology, from drug development through commercialization. For more information, visit www.Neumentum.com.Neumentum Address
252 Colorado AvenueMorristown, NJ
United States